Cart
sales@molnova.com
Home - Products - Others - Other Targets - GR148672X

GR148672X

CAS No. 263890-70-6

GR148672X( —— )

Catalog No. M22441 CAS No. 263890-70-6

GR148672X is an inhibitor of triacyglycerol hydrolase (TGH) (IC50: 4 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 147 In Stock
25MG 260 In Stock
50MG 372 In Stock
100MG 597 In Stock
200MG 835 In Stock
500MG 1233 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    GR148672X
  • Note
    Research use only, not for human use.
  • Brief Description
    GR148672X is an inhibitor of triacyglycerol hydrolase (TGH) (IC50: 4 nM).
  • Description
    GR148672X is an inhibitor of triacyglycerol hydrolase (TGH) (IC50: 4 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TGH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    263890-70-6
  • Formula Weight
    340.32
  • Molecular Formula
    C15H11F3N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:310 mg/mL (910.91 mM; Need ultrasonic and warming)
  • SMILES
    Cc1cccc(NN=C(C(=O)c2cccs2)C(=O)C(F)(F)F)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Catherine Sylvia Borg-Capra, et al. Method of screening for triacyglycerol hydrolase inhibitors . WO 2001016358 A2.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Clindamycin palmitat...

    Clindamycin palmitate HCl is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid and a lincosamide antibiotic.

  • Ebopiprant

    Ebopiprant (OBE022) is an orally available, selective and potent prostaglandin F2α (PGF2α) receptor antagonist that interferes with the binding of PGF0126α to the FPR and can be used in the study of obesity.

  • BCPA

    BCPA is a non-cytotoxic Pin1 modulator.BCPA modulates osteoclast activation and attenuates the reduction of Pin1 protein, thereby inhibiting RANKL-induced receptor activators of osteoclastogenesis.BCPA is used in the study of osteoporosis.

Sign In Join Free